4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-025633
Chief Accounting Officer sold 96 shares at $10.08 ($967)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-21 | Sale : show line 1 in the form | −96 | $10.08 | $967 | 2,832 | D |
| Open-market sales · 96 sh · avg $10.08 · $967 | ||||||
Loading xslF345X05/ownership.xml…